Celanese CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Celanese Corporation announced robust second quarter 2026 financial results, driven by strong commercial performance in both its Engineered Materials and Acetyl Chain segments, alongside strategic operational improvements.
NYSE
Celanese Corporation announced robust second quarter 2026 financial results, showcasing an 18% sequential increase in net sales driven by significant price and volume gains.
NYSE
Celanese US Holdings LLC has issued a notice to redeem all outstanding 4.777% Senior Notes due July 19, 2026, with the redemption expected on June 25, 2026.
NYSE
Celanese Corporation announced its first quarter 2026 financial results, highlighting adjusted EPS of $0.85 and a positive free cash flow of $3 million, while detailing strategic actions to enhance long-term value creation.
NYSE
Celanese Corporation announced first quarter 2026 results, with net sales up 6% sequentially, and raised its full-year free cash flow outlook.
NYSE
Celanese Corporation has expanded its Board of Directors to 10 members with the appointment of industry veteran Anne P. Noonan.
NYSE
Celanese Corporation shareholders successfully elected nine directors, ratified the appointment of KPMG LLP, and approved executive compensation at the 2026 Annual Meeting.
NYSE
Timothy Go has resigned from the Board of Directors of Celanese Corporation, effective February 27, 2026.
NYSE
Scott Sutton has resigned from the Celanese Board of Directors to assume the Chief Executive Officer role at Rayonier Advanced Materials Inc.
NYSE
Celanese US Holdings LLC, a subsidiary of Celanese Corporation, completed a registered offering of $1.4 billion in senior notes to refinance existing debt and for general corporate purposes.
NYSE
Celanese Corporation announced early results and an upsize of its cash tender offers for 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028.
NYSE
Celanese US Holdings LLC, a subsidiary of Celanese Corporation, has priced $1.4 billion in new senior unsecured notes to refinance existing debt and for general corporate purposes.
NYSE
Celanese US Holdings LLC, a subsidiary of Celanese Corporation, has commenced cash tender offers to repurchase up to $1 billion of its outstanding 2027 and 2028 Senior Notes.
NYSE
Celanese Corporation reported strong third-quarter free cash flow and announced the divestiture of its Micromax portfolio, alongside significant debt reduction efforts, despite a challenging macroeconomic environment and a substantial non-cash goodwill impairment.
NYSE
Celanese Corporation reported a significant GAAP loss in Q3 2025 due to asset impairments, but highlighted strong free cash flow and strategic deleveraging actions.
NYSE
Celanese Corporation has signed a definitive agreement to divest its Micromax portfolio to Element Solutions Inc for approximately $500 million, with net proceeds dedicated to deleveraging.
NYSE
Celanese Corporation announced its intent to cease manufacturing operations at its Lanaken, Belgium acetate tow facility by the second half of 2026, citing challenging market conditions and high operating costs.
NYSE
Celanese Corporation has entered into a new five-year, $1.75 billion unsecured revolving credit facility, replacing its previous agreement, and amended its term loan credit agreement to adjust financial covenants.
NYSE
Celanese Corporation reports robust Q2 2025 free cash flow and significant debt reduction, despite persistent demand weakness in key end-markets and a cautious Q3 outlook.
NYSE
Celanese reported Q2 2025 GAAP diluted EPS of $1.90 and adjusted EPS of $1.44, with net sales of $2.5 billion, and achieved significant cash flow and debt reduction.
NYSE
Celanese Corporation's shareholders approved amendments to the company's charter and bylaws at the 2025 Annual Meeting, including removing supermajority voting requirements and adopting majority voting standards.
NYSE
Celanese Corporation announces first quarter 2025 results, highlighting improved free cash flow and strategic actions to navigate a dynamic global economy.
NYSE
Celanese Corporation reported a U.S. GAAP diluted loss per share of $0.15 and adjusted earnings per share of $0.57 for the first quarter of 2025, with net sales of $2.4 billion.
NYSE
Celanese Corporation announces the early results, upsize, and pricing of its cash tender offers for its 4.777% Senior Notes due 2026 and 6.415% Senior Notes due 2027.
NYSE
Celanese Corporation amended its by-laws on March 14, 2025, to designate federal district courts as the exclusive forum for claims arising under the Securities Act of 1933.
NYSE
Celanese US Holdings LLC finalized concurrent registered offerings of senior notes totaling \$1.8 billion and EUR 750 million to fund debt refinancing and general corporate purposes.
NYSE
Celanese Corporation is set to offer $700 million in 6.500% Senior Notes due 2030, $1.1 billion in 6.750% Senior Notes due 2033, and EUR 750 million in 5.000% Senior Notes due 2031 to refinance existing debt and for general corporate purposes.
NYSE
Celanese US Holdings LLC, a subsidiary of Celanese Corporation, has commenced cash tender offers to purchase up to $500 million of its 4.777% Senior Notes due 2026 and up to $250 million of its 6.415% Senior Notes due 2027.
NYSE
Celanese Corporation announces Q4 2024 earnings reflecting a soft demand environment, offset by favorable costs, while outlining strategic priorities including cost reduction, top-line growth, and increased cash flow for deleveraging.
NYSE
Celanese Corporation reported a full year 2024 U.S. GAAP diluted loss per share of $13.86 and adjusted earnings per share of $8.37, with net sales of $10.3 billion.